Compound details
18-Hydroxyepialloyohimbine
| Compound ID | CDAMM02198 |
|---|---|
| Common name | 18-Hydroxyepialloyohimbine | IUPAC name | methyl 17,18-dihydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate |
| Molecular formula | C21H26N2O4 |
| Retention time | 14.66 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 371.197 | Theoretical mz | 371.196 |
| Error | 3.03 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.4963 |
| Inchi key | MMVZFQGCDSDHSV-VDTODRCFNA-N |
|---|---|
| Smiles | O=C(OC)C1C(O)C(O)CC2CN3CCC=4C=5C=CC=CC5NC4C3CC12 |
| Superclass | Alkaloids and derivatives |
| Class | Yohimbine alkaloids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| Q12809 | KCNH2 | HERG | T20251 | SwissTargetPrediction |
| P10635 | CYP2D6 | Cytochrome P450 2D6 | T57392 | SwissTargetPrediction |
| O43570 | CA12 | Carbonic anhydrase XII | T16987 | SwissTargetPrediction |
| Q16790 | CA9 | Carbonic anhydrase IX | T64567 | SwissTargetPrediction |
| P09874 | PARP1 | Poly [ADP-ribose] polymerase-1 | T06273 | SwissTargetPrediction |
| P0DMS8 | ADORA3 | Adenosine A3 receptor | T36059 | SwissTargetPrediction |
| P00915 | CA1 | Carbonic anhydrase I | T13201 | SwissTargetPrediction |
| P42336 | PIK3CA | PI3-kinase p110-alpha subunit | T80276 | SwissTargetPrediction |
| P43405 | SYK | Tyrosine-protein kinase SYK | T62431 | SwissTargetPrediction |
| P16083 | NQO2 | Quinone reductase 2 | T75498 | SwissTargetPrediction |
| P14416 | DRD2 | Dopamine D2 receptor | T67162 | SwissTargetPrediction |
| P13866 | SLC5A1 | Sodium/glucose cotransporter 1 | T54771 | SwissTargetPrediction |
| P23280 | CA6 | Carbonic anhydrase VI | T06569 | SwissTargetPrediction |
| Q9ULX7 | CA14 | Carbonic anhydrase XIV | T31992 | SwissTargetPrediction |
| P22748 | CA4 | Carbonic anhydrase IV | T53378 | SwissTargetPrediction |
| P28223 | HTR2A | Serotonin 2a (5-HT2a) receptor | T32060 | SwissTargetPrediction |
| P31645 | SLC6A4 | Serotonin transporter (by homology) | T27812 | SwissTargetPrediction |
| P41595 | HTR2B | Serotonin 2b (5-HT2b) receptor | T31204 | SwissTargetPrediction |
| P08913 | ADRA2A | Alpha-2a adrenergic receptor | T11448 | SwissTargetPrediction and SEA |
| P08908 | HTR1A | Serotonin 1a (5-HT1a) receptor | T78709 | SwissTargetPrediction |
| P50406 | HTR6 | Serotonin 6 (5-HT6) receptor | T16691 | SwissTargetPrediction |
| Q01959 | SLC6A3 | Dopamine transporter | T55959 | SwissTargetPrediction |
| P45983 | MAPK8 | c-Jun N-terminal kinase 1 | T40097 | SwissTargetPrediction |
| Q8NER1 | TRPV1 | Vanilloid receptor | T83193 | SwissTargetPrediction |
| P08235 | NR3C2 | Mineralocorticoid receptor | T72168 | SwissTargetPrediction |
| P08185 | SERPINA6 | Corticosteroid binding globulin | T88452 | SwissTargetPrediction |
| Q7Z2W7 | TRPM8 | Transient receptor potential cation channel subfamily M member 8 | T41955 | SwissTargetPrediction |
| P35462 | DRD3 | Dopamine D3 receptor | T02551 | SwissTargetPrediction |
| P21728 | DRD1 | Dopamine D1 receptor | T22118 | SwissTargetPrediction and SEA |
| P21918 | DRD5 | Dopamine D5 receptor | T46828 | SEA |
| P18825 | ADRA2C | Adrenergic receptor alpha-2 | T01777 | SwissTargetPrediction and SEA |
| P08183 | ABCB1 | P-glycoprotein 1 | T25258 | SwissTargetPrediction |
| P35372 | OPRM1 | Mu opioid receptor | T47768 | SwissTargetPrediction |
| P25100 | ADRA1D | Alpha-1d adrenergic receptor | T53381 | SwissTargetPrediction |
| P35368 | ADRA1B | Alpha-1b adrenergic receptor | T29500 | SwissTargetPrediction |
| P41145 | OPRK1 | Kappa Opioid receptor | T60693 | SwissTargetPrediction |
| P27695 | APEX1 | DNA-(apurinic or apyrimidinic site) lyase | T13348 | SwissTargetPrediction |
| P52732 | KIF11 | Kinesin-like protein 1 | T28484 | SwissTargetPrediction and SEA |
| P42345 | MTOR | Serine/threonine-protein kinase mTOR | T75243 | SwissTargetPrediction |
| O14757 | CHEK1 | Serine/threonine-protein kinase Chk1 | T62449 | SwissTargetPrediction |
| P06276 | BCHE | Butyrylcholinesterase | T99799 | SwissTargetPrediction |
| P24941 | CDK2 | Cyclin-dependent kinase 2 | T70176 | SwissTargetPrediction |
| P41143 | OPRD1 | Delta opioid receptor | T58992 | SwissTargetPrediction |
| P62942 | FKBP1A | FK506-binding protein 1A | T76059 | SwissTargetPrediction |
| O00767 | SCD | Acyl-CoA desaturase | T10897 | SwissTargetPrediction |
| Q08499 | PDE4D | Phosphodiesterase 4D | T02001 | SwissTargetPrediction |
| P11137 | MAP2 | Microtubule-associated protein 2 | T23276 | SwissTargetPrediction |
| O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | T01003 | SwissTargetPrediction |
| P35348 | ADRA1A | Alpha-1a adrenergic receptor | T92609 | SwissTargetPrediction |
| Q13418 | ILK | Serine/threonine-protein kinase ILK-1 | T13616 | SwissTargetPrediction |
| P31749 | AKT1 | Serine/threonine-protein kinase AKT | T67619 | SwissTargetPrediction |
| O96017 | CHEK2 | Serine/threonine-protein kinase Chk2 | T28713 | SwissTargetPrediction |
| Q5S007 | LRRK2 | Leucine-rich repeat serine/threonine-protein kinase 2 | T08123 | SwissTargetPrediction |
| P05362 | ICAM1 | Intercellular adhesion molecule-1 | T26203 | SwissTargetPrediction |
| P16581 | SELE | Selectin E | T72835 | SwissTargetPrediction |
| Q14432 | PDE3A | Phosphodiesterase 3 | T88975 | SwissTargetPrediction |
| Q15078 | CDK5R1 | Cyclin-dependent kinase 5/CDK5 activator 1 | T09513 | SwissTargetPrediction |
| Q9HBH9 | MKNK2 | MAP kinase signal-integrating kinase 2 | T99160 | SwissTargetPrediction |
| P40763 | STAT3 | Signal transducer and activator of transcription 3 | T29130 | SwissTargetPrediction |
| P09211 | GSTP1 | Glutathione S-transferase Pi | T21669 | SwissTargetPrediction |
| P18089 | ADRA2B | Alpha-2b adrenergic receptor | T41580 | SwissTargetPrediction and SEA |
| O00311 | CDC7 | CDC7/DBF4 (Cell division cycle 7-related protein kinase/Activator of S phase kinase) | T81358 | SwissTargetPrediction |
| Q9NWZ3 | IRAK4 | Interleukin-1 receptor-associated kinase 4 | T55398 | SwissTargetPrediction |
| P41279 | MAP3K8 | Mitogen-activated protein kinase kinase kinase 8 | T00852 | SwissTargetPrediction |
| P55263 | ADK | Adenosine kinase | T91661 | SwissTargetPrediction |
| P06493 | CDK1 | Cyclin-dependent kinase 1/cyclin B1 | T49898 | SwissTargetPrediction |
| Q99808 | SLC29A1 | Equilibrative nucleoside transporter 1 | T13491 | SwissTargetPrediction |
| P07333 | CSF1R | Macrophage colony stimulating factor receptor | T20333 | SwissTargetPrediction |
| P49761 | CLK3 | Dual specificity protein kinase CLK3 | T21585 | SwissTargetPrediction |
| P31639 | SLC5A2 | Sodium/glucose cotransporter 2 | T30085 | SwissTargetPrediction |
| P06737 | PYGL | Liver glycogen phosphorylase | T19184 | SwissTargetPrediction |
| Q99558 | MAP3K14 | Mitogen-activated protein kinase kinase kinase 14 | T95736 | SwissTargetPrediction |
| P42574 | CASP3 | Caspase-3 | T57943 | SwissTargetPrediction |
| Q12908 | SLC10A2 | Ileal bile acid transporter | T24982 | SwissTargetPrediction |
| P41146 | OPRL1 | Nociceptin receptor | T52921 | SwissTargetPrediction |
| P34998 | CRHR1 | Corticotropin releasing factor receptor 1 (by homology) | T45262 | SwissTargetPrediction |
| P35346 | SSTR5 | Somatostatin receptor 5 | T64830 | SEA |
| P30874 | SSTR2 | Somatostatin receptor 2 | T53024 | SEA |
| P31391 | SSTR4 | Somatostatin receptor 4 | T62974 | SEA |
| P30872 | SSTR1 | Somatostatin receptor 1 | T16633 | SEA |
| P32745 | SSTR3 | Somatostatin receptor 3 | T13644 | SEA |
| Q9UQ81 | MCH5 | Caspase-8 | T15700 | SwissTargetPrediction |
| O76074 | PDE5A | Phosphodiesterase 5A | T07663 | SwissTargetPrediction and SEA |
| Q99683 | MAP3K5 | Mitogen-activated protein kinase kinase kinase 5 | T97589 | SwissTargetPrediction |
| Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | T77537 | SwissTargetPrediction |
| O15151 | MDM4 | Protein Mdm4 | T36741 | SwissTargetPrediction |
| P47989 | XDH | Xanthine dehydrogenase | T40954 | SwissTargetPrediction |
| Q13370 | PDE3B | Phosphodiesterase 3B | T21357 | SwissTargetPrediction |
| Q9Y5X9 | LIPG | Endothelial lipase | T19368 | SwissTargetPrediction |
| O00408 | PDE2A | Phosphodiesterase 2A | T77400 | SwissTargetPrediction |
| Q92630 | DYRK2 | Dual-specificity tyrosine-phosphorylation regulated kinase 2 | T39486 | SwissTargetPrediction |
| Q13464 | ROCK1 | Rho-associated protein kinase 1 | T51282 | SwissTargetPrediction |
| P15559 | NQO1 | Quinone reductase 1 | T52389 | SwissTargetPrediction |
| Q00796 | SORD | Sorbitol dehydrogenase | T59445 | SwissTargetPrediction |
| Q15759 | MAPK11 | MAP kinase p38 beta | T55729 | SwissTargetPrediction |
| P53582 | METAP1 | Methionine aminopeptidase 1 | T42337 | SwissTargetPrediction |
| O00142 | TK2 | Thymidine kinase, mitochondrial | T22976 | SwissTargetPrediction |
| Q9HCR9 | PDE11A | Phosphodiesterase 11A | T99802 | SEA |
| P49862 | KLK7 | Kallikrein-7 | T79155 | SEA |
| Q9HCN6 | GP6 | Platelet glycoprotein VI | T60514 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T20251 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | Q12809 | KCNH2 |
| T57392 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P10635 | CYP2D6 |
| T16987 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O43570 | CA12 |
| T16987 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | O43570 | CA12 |
| T64567 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16790 | CA9 |
| T06273 | DI0006 | Acquired cutaneous blood vessel malformation | [ICD-11: EF20] | P09874 | PARP1 |
| T06273 | DI0143 | Fallopian tube cancer | [ICD-11: 2C74] | P09874 | PARP1 |
| T06273 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P09874 | PARP1 |
| T06273 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P09874 | PARP1 |
| T36059 | DI0351 | Psoriasis | [ICD-11: EA90] | P0DMS8 | ADORA3 |
| T36059 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P0DMS8 | ADORA3 |
| T13201 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00915 | CA1 |
| T13201 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00915 | CA1 |
| T80276 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P42336 | PIK3CA |
| T80276 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P42336 | PIK3CA |
| T80276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P42336 | PIK3CA |
| T62431 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P43405 | SYK |
| T75498 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P16083 | NQO2 |
| T67162 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P14416 | DRD2 |
| T67162 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P14416 | DRD2 |
| T67162 | DI0037 | Asthma | [ICD-11: CA23] | P14416 | DRD2 |
| T67162 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P14416 | DRD2 |
| T67162 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P14416 | DRD2 |
| T67162 | DI0063 | Breathing abnormality | [ICD-11: MD11] | P14416 | DRD2 |
| T67162 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P14416 | DRD2 |
| T67162 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P14416 | DRD2 |
| T67162 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P14416 | DRD2 |
| T67162 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P14416 | DRD2 |
| T67162 | DI0137 | Essential hypertension | [ICD-11: BA00] | P14416 | DRD2 |
| T67162 | DI0142 | Faecal incontinence | [ICD-11: ME07] | P14416 | DRD2 |
| T67162 | DI0156 | Gangrene | [ICD-11: MC85] | P14416 | DRD2 |
| T67162 | DI0166 | Glaucoma | [ICD-11: 9C61] | P14416 | DRD2 |
| T67162 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P14416 | DRD2 |
| T67162 | DI0185 | Hyperaemia | [ICD-11: 9A61-9B7Y] | P14416 | DRD2 |
| T67162 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P14416 | DRD2 |
| T67162 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P14416 | DRD2 |
| T67162 | DI0205 | Inborn porphyrin/heme metabolism error | [ICD-11: 5C58] | P14416 | DRD2 |
| T67162 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P14416 | DRD2 |
| T67162 | DI0222 | Itching | [ICD-11: 1F28-1G07] | P14416 | DRD2 |
| T67162 | DI0264 | Migraine | [ICD-11: 8A80] | P14416 | DRD2 |
| T67162 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P14416 | DRD2 |
| T67162 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P14416 | DRD2 |
| T67162 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P14416 | DRD2 |
| T67162 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P14416 | DRD2 |
| T67162 | DI0340 | Postpartum haemorrhage | [ICD-11: JA43] | P14416 | DRD2 |
| T67162 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P14416 | DRD2 |
| T67162 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P14416 | DRD2 |
| T67162 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P14416 | DRD2 |
| T67162 | DI0396 | Substance abuse | [ICD-11: 6C40] | P14416 | DRD2 |
| T67162 | DI0408 | Thyrotoxicosis | [ICD-11: 5A02] | P14416 | DRD2 |
| T67162 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P14416 | DRD2 |
| T54771 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P13866 | SLC5A1 |
| T54771 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P13866 | SLC5A1 |
| T54771 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P13866 | SLC5A1 |
| T06569 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P23280 | CA6 |
| T06569 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P23280 | CA6 |
| T31992 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q9ULX7 | CA14 |
| T31992 | DI0204 | Inborn metabolism deficiency | [ICD-11: 5C50-5C59] | Q9ULX7 | CA14 |
| T53378 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P22748 | CA4 |
| T53378 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22748 | CA4 |
| T53378 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P22748 | CA4 |
| T32060 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P28223 | HTR2A |
| T32060 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P28223 | HTR2A |
| T32060 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P28223 | HTR2A |
| T32060 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P28223 | HTR2A |
| T32060 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P28223 | HTR2A |
| T32060 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28223 | HTR2A |
| T32060 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P28223 | HTR2A |
| T27812 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P31645 | SLC6A4 |
| T27812 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P31645 | SLC6A4 |
| T27812 | DI0087 | Chronic pain | [ICD-11: MG30] | P31645 | SLC6A4 |
| T27812 | DI0096 | concerning food/fluid intake symptom | [ICD-11: MG43] | P31645 | SLC6A4 |
| T27812 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P31645 | SLC6A4 |
| T27812 | DI0105 | Cough | [ICD-11: MD12] | P31645 | SLC6A4 |
| T27812 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P31645 | SLC6A4 |
| T27812 | DI0264 | Migraine | [ICD-11: 8A80] | P31645 | SLC6A4 |
| T27812 | DI0301 | Nicotine use disorder | [ICD-11: 6C4A] | P31645 | SLC6A4 |
| T27812 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P31645 | SLC6A4 |
| T27812 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P31645 | SLC6A4 |
| T31204 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P41595 | HTR2B |
| T31204 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P41595 | HTR2B |
| T31204 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P41595 | HTR2B |
| T31204 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P41595 | HTR2B |
| T11448 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P08913 | ADRA2A |
| T11448 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | P08913 | ADRA2A |
| T11448 | DI0396 | Substance abuse | [ICD-11: 6C40] | P08913 | ADRA2A |
| T78709 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P08908 | HTR1A |
| T78709 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P08908 | HTR1A |
| T78709 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08908 | HTR1A |
| T78709 | DI0264 | Migraine | [ICD-11: 8A80] | P08908 | HTR1A |
| T78709 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P08908 | HTR1A |
| T16691 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P50406 | HTR6 |
| T16691 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P50406 | HTR6 |
| T55959 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | Q01959 | SLC6A3 |
| T55959 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | Q01959 | SLC6A3 |
| T55959 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | Q01959 | SLC6A3 |
| T55959 | DI0290 | Narcolepsy | [ICD-11: 7A20] | Q01959 | SLC6A3 |
| T55959 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | Q01959 | SLC6A3 |
| T55959 | DI0331 | Parkinsonism | [ICD-11: 8A00] | Q01959 | SLC6A3 |
| T40097 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45983 | MAPK8 |
| T83193 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q8NER1 | TRPV1 |
| T72168 | DI0018 | Adrenocortical insufficiency | [ICD-11: 5A74] | P08235 | NR3C2 |
| T72168 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P08235 | NR3C2 |
| T72168 | DI0100 | Contraceptive management | [ICD-11: QA21] | P08235 | NR3C2 |
| T72168 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P08235 | NR3C2 |
| T72168 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08235 | NR3C2 |
| T72168 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P08235 | NR3C2 |
| T88452 | DI0037 | Asthma | [ICD-11: CA23] | P08185 | SERPINA6 |
| T88452 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | P08185 | SERPINA6 |
| T88452 | DI0362 | Respiratory system disease | [ICD-11: CB40-CB7Z] | P08185 | SERPINA6 |
| T41955 | DI0422 | Upper respiratory tract disorder | [ICD-11: CA0Z] | Q7Z2W7 | TRPM8 |
| T02551 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P35462 | DRD3 |
| T02551 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P35462 | DRD3 |
| T22118 | DI0003 | Abortion | [ICD-11: JA00] | P21728 | DRD1 |
| T22118 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21728 | DRD1 |
| T22118 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P21728 | DRD1 |
| T22118 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P21728 | DRD1 |
| T46828 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21918 | DRD5 |
| T01777 | DI0166 | Glaucoma | [ICD-11: 9C61] | P18825 | ADRA2C |
| T01777 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P18825 | ADRA2C |
| T01777 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P18825 | ADRA2C |
| T01777 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18825 | ADRA2C |
| T01777 | DI0310 | Ocular disease | [ICD-11: N.A.] | P18825 | ADRA2C |
| T01777 | DI0396 | Substance abuse | [ICD-11: 6C40] | P18825 | ADRA2C |
| T25258 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08183 | ABCB1 |
| T47768 | DI0013 | Acute pain | [ICD-11: MG31] | P35372 | OPRM1 |
| T47768 | DI0059 | Bowel habit change | [ICD-11: ME05] | P35372 | OPRM1 |
| T47768 | DI0087 | Chronic pain | [ICD-11: MG30] | P35372 | OPRM1 |
| T47768 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P35372 | OPRM1 |
| T47768 | DI0105 | Cough | [ICD-11: MD12] | P35372 | OPRM1 |
| T47768 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35372 | OPRM1 |
| T47768 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P35372 | OPRM1 |
| T47768 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P35372 | OPRM1 |
| T47768 | DI0228 | Large intestine motility disorder | [ICD-11: DB32] | P35372 | OPRM1 |
| T47768 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | P35372 | OPRM1 |
| T47768 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35372 | OPRM1 |
| T47768 | DI0349 | Pruritus | [ICD-11: EC90] | P35372 | OPRM1 |
| T47768 | DI0374 | Sensation disturbance | [ICD-11: MB40] | P35372 | OPRM1 |
| T53381 | DI0166 | Glaucoma | [ICD-11: 9C61] | P25100 | ADRA1D |
| T53381 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P25100 | ADRA1D |
| T53381 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P25100 | ADRA1D |
| T53381 | DI0348 | Prostate hyperplasia | [ICD-11: GA90] | P25100 | ADRA1D |
| T53381 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | P25100 | ADRA1D |
| T53381 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P25100 | ADRA1D |
| T29500 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P35368 | ADRA1B |
| T29500 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P35368 | ADRA1B |
| T29500 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | P35368 | ADRA1B |
| T29500 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P35368 | ADRA1B |
| T29500 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35368 | ADRA1B |
| T60693 | DI0304 | Non-specific cutaneous vascular symptom | [ICD-11: ME64] | P41145 | OPRK1 |
| T60693 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P41145 | OPRK1 |
| T60693 | DI0349 | Pruritus | [ICD-11: EC90] | P41145 | OPRK1 |
| T13348 | DI0365 | Retinopathy | [ICD-11: 9B71] | P27695 | APEX1 |
| T13348 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P27695 | APEX1 |
| T28484 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P52732 | KIF11 |
| T28484 | DI0172 | Head and neck cancer | [ICD-11: 2D42] | P52732 | KIF11 |
| T28484 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P52732 | KIF11 |
| T28484 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P52732 | KIF11 |
| T28484 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P52732 | KIF11 |
| T28484 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P52732 | KIF11 |
| T28484 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P52732 | KIF11 |
| T28484 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P52732 | KIF11 |
| T75243 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P42345 | MTOR |
| T75243 | DI0085 | Chronic myelomonocytic leukaemia | [ICD-11: 2A40] | P42345 | MTOR |
| T75243 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P42345 | MTOR |
| T75243 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P42345 | MTOR |
| T75243 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P42345 | MTOR |
| T75243 | DI0413 | Transplant rejection | [ICD-11: NE84] | P42345 | MTOR |
| T62449 | DI0027 | Anal cancer | [ICD-11: 2C00] | O14757 | CHEK1 |
| T62449 | DI0172 | Head and neck cancer | [ICD-11: 2D42] | O14757 | CHEK1 |
| T62449 | DI0183 | Hodgkin lymphoma | [ICD-11: 2B30] | O14757 | CHEK1 |
| T62449 | DI0238 | Lung cancer | [ICD-11: 2C25] | O14757 | CHEK1 |
| T62449 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O14757 | CHEK1 |
| T62449 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | O14757 | CHEK1 |
| T62449 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14757 | CHEK1 |
| T62449 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14757 | CHEK1 |
| T99799 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P06276 | BCHE |
| T99799 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P06276 | BCHE |
| T70176 | DI0060 | Brain cancer | [ICD-11: 2A00] | P24941 | CDK2 |
| T70176 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P24941 | CDK2 |
| T70176 | DI0238 | Lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P24941 | CDK2 |
| T70176 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P24941 | CDK2 |
| T70176 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P24941 | CDK2 |
| T70176 | DI0406 | Thymoma | [ICD-11: 2C27] | P24941 | CDK2 |
| T58992 | DI0059 | Bowel habit change | [ICD-11: ME05] | P41143 | OPRD1 |
| T58992 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P41143 | OPRD1 |
| T58992 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P41143 | OPRD1 |
| T76059 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P62942 | FKBP1A |
| T76059 | DI0349 | Pruritus | [ICD-11: EC90] | P62942 | FKBP1A |
| T76059 | DI0413 | Transplant rejection | [ICD-11: NE84] | P62942 | FKBP1A |
| T10897 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O00767 | SCD |
| T02001 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | Q08499 | PDE4D |
| T23276 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P11137 | MAP2 |
| T23276 | DI0252 | Melanoma | [ICD-11: 2C30] | P11137 | MAP2 |
| T23276 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P11137 | MAP2 |
| T23276 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11137 | MAP2 |
| T01003 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | O75460 | ERN1 |
| T92609 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P35348 | ADRA1A |
| T92609 | DI0348 | Prostate hyperplasia | [ICD-11: GA90] | P35348 | ADRA1A |
| T13616 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q13418 | ILK |
| T67619 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P31749 | AKT1 |
| T28713 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O96017 | CHEK2 |
| T08123 | DI0331 | Parkinsonism | [ICD-11: 8A00] | Q5S007 | LRRK2 |
| T26203 | DI0436 | Visual system disease | [ICD-11: 9E1Z] | P05362 | ICAM1 |
| T72835 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P16581 | SELE |
| T72835 | DI0037 | Asthma | [ICD-11: CA23] | P16581 | SELE |
| T72835 | DI0039 | Atopic eczema | [ICD-11: EA80] | P16581 | SELE |
| T72835 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P16581 | SELE |
| T72835 | DI0088 | Circulatory system disease | [ICD-11: BE2Z] | P16581 | SELE |
| T72835 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P16581 | SELE |
| T72835 | DI0351 | Psoriasis | [ICD-11: EA90] | P16581 | SELE |
| T88975 | DI0035 | Arterial occlusive disease | [ICD-11: BD40] | Q14432 | PDE3A |
| T88975 | DI0037 | Asthma | [ICD-11: CA23] | Q14432 | PDE3A |
| T88975 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | Q14432 | PDE3A |
| T88975 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | Q14432 | PDE3A |
| T99160 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q9HBH9 | MKNK2 |
| T99160 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | Q9HBH9 | MKNK2 |
| T99160 | DI0235 | Liver cancer | [ICD-11: 2C12] | Q9HBH9 | MKNK2 |
| T99160 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q9HBH9 | MKNK2 |
| T99160 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9HBH9 | MKNK2 |
| T29130 | DI0351 | Psoriasis | [ICD-11: EA90] | P40763 | STAT3 |
| T21669 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P09211 | GSTP1 |
| T41580 | DI0396 | Substance abuse | [ICD-11: 6C40] | P18089 | ADRA2B |
| T81358 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O00311 | CDC7 |
| T81358 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O00311 | CDC7 |
| T55398 | DI0039 | Atopic eczema | [ICD-11: EA80] | Q9NWZ3 | IRAK4 |
| T55398 | DI0109 | Cutaneous lupus erythematosus | [ICD-11: EB50-EB5Z] | Q9NWZ3 | IRAK4 |
| T55398 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q9NWZ3 | IRAK4 |
| T55398 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q9NWZ3 | IRAK4 |
| T55398 | DI0351 | Psoriasis | [ICD-11: EA90] | Q9NWZ3 | IRAK4 |
| T55398 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9NWZ3 | IRAK4 |
| T00852 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | P41279 | MAP3K8 |
| T91661 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P55263 | ADK |
| T49898 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P06493 | CDK1 |
| T49898 | DI0238 | Lung cancer | [ICD-11: 2C25] | P06493 | CDK1 |
| T49898 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P06493 | CDK1 |
| T49898 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P06493 | CDK1 |
| T49898 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06493 | CDK1 |
| T13491 | DI0030 | Angina pectoris | [ICD-11: BA40] | Q99808 | SLC29A1 |
| T20333 | DI0058 | Bone/articular cartilage neoplasm | [ICD-11: 2F7B] | P07333 | CSF1R |
| T30085 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P31639 | SLC5A2 |
| T30085 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P31639 | SLC5A2 |
| T30085 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P31639 | SLC5A2 |
| T57943 | DI0060 | Brain cancer | [ICD-11: 2A00] | P42574 | CASP3 |
| T24982 | DI0349 | Pruritus | [ICD-11: EC90] | Q12908 | SLC10A2 |
| T52921 | DI0039 | Atopic eczema | [ICD-11: EA80] | P41146 | OPRL1 |
| T52921 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P41146 | OPRL1 |
| T52921 | DI0173 | Headache | [ICD-11: 8A80-8A84] | P41146 | OPRL1 |
| T52921 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P41146 | OPRL1 |
| T45262 | DI0394 | Staphylococcal/streptococcal disease | [ICD-11: 1B5Y] | P34998 | CRHR1 |
| T64830 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P35346 | SSTR5 |
| T53024 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P30874 | SSTR2 |
| T53024 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P30874 | SSTR2 |
| T53024 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P30874 | SSTR2 |
| T62974 | DI0087 | Chronic pain | [ICD-11: MG30] | P31391 | SSTR4 |
| T62974 | DI0179 | Hepatitis virus infection | [ICD-11: 1E50-1E51] | P31391 | SSTR4 |
| T16633 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P30872 | SSTR1 |
| T16633 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P30872 | SSTR1 |
| T13644 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P32745 | SSTR3 |
| T15700 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | Q9UQ81 | MCH5 |
| T15700 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9UQ81 | MCH5 |
| T07663 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | O76074 | PDE5A |
| T07663 | DI0213 | Innate/adaptive immunodeficiency | [ICD-11: 4A00] | O76074 | PDE5A |
| T07663 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | O76074 | PDE5A |
| T07663 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | O76074 | PDE5A |
| T97589 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | Q99683 | MAP3K5 |
| T97589 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | Q99683 | MAP3K5 |
| T36741 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | O15151 | MDM4 |
| T36741 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O15151 | MDM4 |
| T36741 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | O15151 | MDM4 |
| T36741 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O15151 | MDM4 |
| T40954 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | P47989 | XDH |
| T40954 | DI0266 | Mineral deficiency | [ICD-11: 5B5K] | P47989 | XDH |
| T19368 | DI0081 | Chronic arterial occlusive disease | [ICD-11: BD4Z] | Q9Y5X9 | LIPG |
| T19368 | DI0091 | Coagulation defect | [ICD-11: 3B10] | Q9Y5X9 | LIPG |
| T19368 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q9Y5X9 | LIPG |
| T77400 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | O00408 | PDE2A |
| T77400 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | O00408 | PDE2A |
| T77400 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | O00408 | PDE2A |
| T77400 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | O00408 | PDE2A |
| T51282 | DI0166 | Glaucoma | [ICD-11: 9C61] | Q13464 | ROCK1 |
| T52389 | DI0079 | Choreiform disorder | [ICD-11: 8A01] | P15559 | NQO1 |
| T52389 | DI0090 | CNS anomalies syndrome | [ICD-11: LD20] | P15559 | NQO1 |
| T52389 | DI0202 | Inborn energy metabolism error | [ICD-11: 5C53] | P15559 | NQO1 |
| T52389 | DI0215 | Intellectual development disorder | [ICD-11: LD90] | P15559 | NQO1 |
| T52389 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P15559 | NQO1 |
| T52389 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P15559 | NQO1 |
| T55729 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | Q15759 | MAPK11 |
| T55729 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q15759 | MAPK11 |
| T22976 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | O00142 | TK2 |
| T60514 | DI0035 | Arterial occlusive disease | [ICD-11: BD40] | Q9HCN6 | GP6 |
| T60514 | DI0074 | Cerebral ischaemic stroke | [ICD-11: 8B11] | Q9HCN6 | GP6 |